The SH-SY5Y cell line is one of the most widely used cell models for studying neurodegenerative diseases. In this post, we provide details on how to utilize the SH-SY5Y cell line for research purposes, including protocols for successful gene editing and cell culture.
In recent years, SH-SY5Y cells have been widely used as an in vitro model in studies related to immunology, neurodegenerative diseases and neurotoxicity. Data indicate that high levels of brain cholesterol can promote the accumulation of β-amyloid (Aβ) and oxidative stress. SH-SY5Y serves as a model for brain disorders since the addition of specific compounds can convert cells into various types of functional neurons. In one study, to further explore the underlying mechanisms, researchers used SH-SY5Y cells to verify the effects of a high-cholesterol environment on neuronal cells. [1]
Image source:《Translational neurodegeneration》
(https://doi.org/10.1186/s40035-023-00343-3)
Cell Line Model Name: SH-SY5Y (Human Neuroblastoma Cells)
Catalog Number: ATCC CRL-2266
Growth Characteristics: Grows in clusters or aggregates, with a small portion remaining in suspension
Culture Conditions: MEM/F12 + 10% FBS + Glutamine + NEAA + Sodium Pyruvate
Culture Environment: 95% air + 5% CO₂; 37°C
The SH-SY5Y cell line is a subline that originated from the third clone of the neuroblastoma cell line SK-N-SH (ATCC HTB-11) (SK-N-SH → SH-SY → SH-SY5 → SH-SY5Y). SK-N-SH was first established in 1970 from a metastatic bone tumor in a 4-year-old cancer patient. SH-SY5Y cells are one of the most widely used cell models for studying neurodegenerative diseases because mature neurons do not divide, while SH-SY5Y cells are capable of continuous proliferation. As undifferentiated cells. exhibiting neuroblast-like morphology and expressing immature neuronal markers. Genetically edited SH-SY5Y cell lines are becoming increasingly important tools in pharmacology and neuroscience research.
Alzheimer's Disease: Used to study the toxic effects of β-amyloid (Aβ) and Tau protein accumulation on neurons.
Parkinson's Disease: Employed to investigate the function of dopaminergic neurons and the aggregation of α-synuclein.
Assessment of the toxic effects of various chemicals, drugs, and environmental toxins on neurons.
SH-SY5Y cells can be induced to differentiate into neuron-like cells using retinoic acid (RA) or other chemical inducers, making them a valuable model for studying the mechanisms of neuronal differentiation and maturation.
Study the role of specific genes in neuronal function and disease through techniques such as gene knockout, overexpression, or RNA interference.
Investigate neuronal signal transduction pathways, such as calcium signaling, the MAPK/ERK pathway, and the PI3K/Akt pathway.
In practice, SH-SY5Y cells are relatively sensitive and proliferate slowly, making it challenging to prepare single clones. To ensure the stability of SH-SY5Y cells and the reliability of experimental results, it is essential to master effective cell culture techniques that facilitate the unique needs of this cell line model.
Common genetic modifications in the SH-SY5Y cell line include knockout (KO), point mutation (PM), knock-in (KI), overexpression (OE), and interference. Cyagen has optimized preparation and single-cell cloning conditions to deliver monoclonal gene-edited SH-SY5Y cell line models, significantly enhancing the accuracy and reliability of experiments. This approach provides a solid foundation for neuroscience research, enabling more precise investigations into neuronal functions and disease mechanisms.
Based on the Smart-CRISPR™ cell gene editing system, Cyagen offers custom SH-SY5Y KO (knockout) cell services, delivering single clone homozygous lines. We utilize an optimized transfection system to directly deliver RNP (ribonucleoprotein) into cells, achieving gRNA cutting efficiency exceeding 90%. Compared to plasmid and virus-mediated CRISPR/Cas methods, this approach significantly increases cutting efficiency while markedly reducing off-target effects, enabling more precise cutting of target DNA sequences.
Using the Smart-CRISPR™ cell gene editing system, we offer precise and efficient SH-SY5Y point mutation and knock-in (KI) cell customization services. Through an optimized α-donor system, humanized Cas proteins, gRNA, and donor DNA are co-transfected into the target cells, resulting in high-efficiency homologous recombination with an HDR (homology-directed repair) rate of up to 49%. This enables the delivery of single clone homozygous lines, providing a robust tool for advanced research.
Cyagen has optimized and upgraded the transfection vector system, leveraging years of expertise in cell biology to establish a mature and stable gene overexpression experimental system. We offer SH-SY5Y stable cell pools or single clone cell lines that stably express exogenous genes or RNA interference elements, achieving over a 10-fold increase in protein expression. This provides researchers with reliable tools for consistent gene expression studies.
Cyagen offers a one-stop in vitro service platform for cell line/iPSC gene editing, featuring advanced cell reprogramming, genetic engineering, and cellular differentiation technologies. By integrating our one-stop phenotypic analysis platform, we can provide in vitro model development and testing services for cell lines across various disease applications. Our optimized CRISPR-Pro technology enables rapid gene editing, including the excision of large fragments, large fragment knockin, and point mutations with stable expression across various cell lines.
Contact our experts and take advantage of our optimized CRISPR-Pro gene edited cell line modeling service platform for low-cost cell line generation with rapid turnaround and stable expression.
>>Learn more about our custom cell line gene editing services
References:
[1]de Dios, Cristina., de Dios, Cristina., de Dios, Cristina., Abadin, Xenia., and Roca-Agujetas, Vicente.. "Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis." Translational neurodegeneration.